Cargando…
Evaluation of autoantibody signatures in meningioma patients using human proteome arrays
Meningiomas are one of the most common tumors of the Central nervous system (CNS). This study aims to identify the autoantibody biomarkers in meningiomas using high-density human proteome arrays (~17,000 full-length recombinant human proteins). Screening of sera from 15 unaffected healthy individual...
Autores principales: | Gupta, Shabarni, Mukherjee, Shuvolina, Syed, Parvez, Pandala, Narendra Goud, Choudhary, Saket, Singh, Vedita Anand, Singh, Namrata, Zhu, Heng, Epari, Sridhar, Noronha, Santosh B, Moiyadi, Aliasgar, Srivastava, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601665/ https://www.ncbi.nlm.nih.gov/pubmed/28938569 http://dx.doi.org/10.18632/oncotarget.16997 |
Ejemplares similares
-
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays
por: Syed, Parvez, et al.
Publicado: (2015) -
A Protein Microarray-Based Investigation of Cerebrospinal Fluid Reveals Distinct Autoantibody Signature in Low and High-Grade Gliomas
por: Gahoi, Nikita, et al.
Publicado: (2020) -
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
por: Sharma, Samridhi, et al.
Publicado: (2014) -
Comprehending Meningioma Signaling Cascades Using Multipronged Proteomics Approaches & Targeted Validation of Potential Markers
por: Mukherjee, Shuvolina, et al.
Publicado: (2020) -
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors
por: Ghantasala, Saicharan, et al.
Publicado: (2021)